Feng et al. identified PDGFRB as a therapeutic target of ankylosing spondylitis from microarray datasets and found that PDGFRB was upregulated during the osteogenesis of fibroblasts of AS [24]. Here, PDGFRB is linked to ankylosing spondylitis.